Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Transdermal Patch market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.
This report presents the market size and development trends by detailing the Transdermal Patch market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transdermal Patch market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transdermal Patch industry and will help you to build a panoramic view of the industrial development.
Transdermal Patch Market, By Type:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Transdermal Patch Market, By Application:
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
Some of the leading players are as follows:
Mundipharma
Rfl Pharmaceutical
Hisamitsu Pharmaceutical
Johnson & Johnson
Actavis
Teikoku Pharma
Mylan
Changzhou Siyao
Novartis
Henan Lingrui Pharmaceutical
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Transdermal Patch Market: Technology Type Analysis
-
4.1 Transdermal Patch Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Transdermal Patch Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Fentanyl Transdermal Patch
4.3.2 Nicotine Transdermal Patch
4.3.3 Buprenorphine Transdermal Patch
4.3.4 Clonidine Transdermal Patch
4.3.5 Oxybutynin Transdermal Patch
4.3.6 Others
5 Transdermal Patch Market: Product Analysis
-
5.1 Transdermal Patch Product Market Share Analysis, 2018 & 2026
-
5.2 Transdermal Patch Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Transdermal Patch Market: Application Analysis
-
6.1 Transdermal Patch Application Market Share Analysis, 2018 & 2026
-
6.2 Transdermal Patch Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Used to Stop Smoking Cigarettes
6.3.2 Used to Treat High Blood Pressure
6.3.3 Used to Relieve Severe Pain
6.3.4 Used to Treat an Overactive Bladder
7 Transdermal Patch Market: Regional Analysis
-
7.1 Transdermal Patch Regional Market Share Analysis, 2018 & 2026
-
7.2 Transdermal Patch Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Mundipharma
9.1.1 Mundipharma Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Rfl Pharmaceutical
9.2.1 Rfl Pharmaceutical Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Hisamitsu Pharmaceutical
9.3.1 Hisamitsu Pharmaceutical Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Actavis
9.5.1 Actavis Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Teikoku Pharma
9.6.1 Teikoku Pharma Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Mylan
9.7.1 Mylan Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Changzhou Siyao
9.8.1 Changzhou Siyao Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Novartis
9.9.1 Novartis Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Henan Lingrui Pharmaceutical
9.10.1 Henan Lingrui Pharmaceutical Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 82 Figures and 139 Tables)
Figure Fentanyl Transdermal Patch Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Nicotine Transdermal Patch Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Buprenorphine Transdermal Patch Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Clonidine Transdermal Patch Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Oxybutynin Transdermal Patch Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Others Transdermal Patch market, 2015 - 2026 (USD Million)
Figure Used to Stop Smoking Cigarettes market, 2015 - 2026 (USD Million)
Figure Used to Treat High Blood Pressure market, 2015 - 2026 (USD Million)
Figure Used to Relieve Severe Pain market, 2015 - 2026 (USD Million)
Figure Used to Treat an Overactive Bladder market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Transdermal Patch market, by country, 2015 - 2026 (USD Million)
-
Table North America Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table North America Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table North America Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Canada Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Canada Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Patch market, by country, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Germany Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Germany Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table France Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table France Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Italy Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Italy Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Spain Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Spain Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Patch market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table China Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table China Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Japan Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Japan Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table India Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table India Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Patch market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Patch market, by country, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Transdermal Patch market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal Patch market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal Patch market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Mundipharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Rfl Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hisamitsu Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Actavis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teikoku Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Changzhou Siyao Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Henan Lingrui Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
